According
to a new market report published by Transparency Market Research “Transcriptomics Technologies Market (Microarrays,
PCR, Gene Regulation and Next Generation Sequencing) -
Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,”
the global transcriptomics technologies market was valued at USD 1.65
billion in 2012 and is expected to grow at a CAGR of 15.9% from 2013 to 2019,
to reach an estimated value of USD 4.6 billion in 2019.

Transcriptome
refers to the complete set of all coding and non-coding ribonucleic acid (RNA)
molecules present in an individual or population of cells. Transcriptome
accounts for about less than 5% of the total genome. Transcriptomics research
refers to the study of functional and structural aspects of RNA transcripts in
a given cell. This research provides insights about the gene expression and
gene regulation mechanisms in normal and diseased cells such as cancerous
cells. In addition it aids in identification of novel gene sequences and potential
drug targets. With the increasing preference for personalized medicine and
companion diagnostics, transcriptomics technologies promises increased
participation of pharmaceutical and biotechnology companies in healthcare and medical
research projects. The most important factors favoring growth of global
transcriptomics market include consistent technological upgradation followed by
increased healthcare and R&D expenditure by pharmaceutical and
biotechnology companies. Also, continuous exploration of biomarkers and novel
gene sequences will drive the growth and acceptance of transcriptomics
technologies across the globe.

Lack
of effective bioinformatics tools employed for transcriptome analysis is one of
the major factors expected to hamper the ready acceptance of transcriptome
analysis tools and services. In addition, lack of awareness about genomic
medicine and domain expertise are the other factors which might restrain the
market growth. Increased research investments made by several pharmaceutical
and biotechnology companies to develop targeted therapeutics, provide a growth
opportunity to the transcriptomics technologies. Currently, the trend of
contract research outsourcing is advantageous for the development and
commercialization of transcriptomics research outcomes.

The
global transcriptomics technologies market can be categorized by technology,
application and geography. RNA sequencing technologies have surpassed the usage
of microarrays in drug discovery and research with increased efficiency and
reliability. Transcriptomics technologies market for microarrays was the most
prominent segment of the market in 2012 by revenue. However, next generation
sequencing technologies are steadily surpassing the use of microarrays, owing
to their higher efficiency, reliability and capabilities. Extensive research
activities and technological evolution of sequencing platforms further propel
adoption of next generation sequencing technologies. Another attractive segment
of this market is that of gene regulation technologies such as micro RNA and
RNA interference technology. These technologies regulate proper functioning of
the genes in normal as well as diseased cells. It is estimated that the market
for gene regulation technologies will grow at a CAGR of over 15% from 2013 to
2019.

At the
regional level, North America was the largest market in 2012 for transcriptomics
technologies followed by the European region. Presence of sophisticated and
well infrastructured research and medical laboratories followed by increased
participation of respective governments in healthcare sector will propel growth
and acceptance of transcriptomics research in North American market. The
Asia-Pacific region is expected to record commendable growth by 2019 due to huge
untapped potential population, rising disposable income, increased healthcare
investments and extensive research carried out in the biotechnology field.

Transcriptomics
technologies market is characterized by the presence of established players as
well as new players solely operating in this market. The major companies
competing in this market are Agilent Technologies, Inc., Affymetrix, Inc., Life
Technologies Corporation, Illumina, Inc., F-Hoffmann La Roche Ltd. and Thermo
Fisher Scientific.

The
global transcriptomics technologies market is segmented as follows:

Transparency
Market Research is a global market intelligence company, providing global
business information reports and services. Our exclusive blend of quantitative
forecasting and trends analysis provides forward-looking insight for thousands
of decision makers. Our experienced team of Analysts, Researchers, and
Consultants, use proprietary data sources and various tools and techniques to
gather, and analyze information.

Our
data repository is continuously updated and revised by a team of research experts,
so that it always reflects the latest trends and information. With a broad
research and analysis capability, Transparency Market Research employs rigorous
primary and secondary research techniques in developing distinctive data sets
and research material for business reports.